Retatrutide Dosage Protocol for UAE Residents: Beginner to Advanced (2026)

Retatrutide Dosage Protocol for UAE Residents: Beginner to Advanced (2026)

Retatrutide Dosage Protocol for UAE Residents: Beginner to Advanced (2026)

Quick Reference
  • Starting dose: 1–2mg subcutaneous injection, once weekly
  • Escalate every 4 weeks based on tolerance
  • Maximum Phase 2 dose: 12mg/week (24.2% weight loss over 48 weeks)
  • Reconstitute with 1–2ml bacteriostatic water per vial; refrigerate at 2–8°C
  • In Dubai's heat: use insulated bag for transport; discard if above 25°C for 48+ hours

Getting the dose right is the most important factor in a successful retatrutide protocol. Retatrutide is a triple agonist — it activates GLP-1, GIP, and glucagon receptors simultaneously — making it significantly more potent than Mounjaro or Ozempic. Starting too high causes unnecessary nausea; staying too low means missing the weight loss you came for. This guide walks UAE buyers through the exact escalation protocol used in Phase 2 TRIUMPH trials, reconstitution steps, and how to adapt the protocol for life in the UAE.

1–2mgWeek 1–4 starting dose
12mgMaximum Phase 2 tested dose
24.2%Average weight loss at 12mg (48 weeks)

Why Dosing Matters More with Retatrutide Than Other GLP-1s

Retatrutide is not a standard GLP-1 agonist. Its third mechanism — glucagon receptor activation — drives additional fat oxidation and energy expenditure that Mounjaro and Ozempic do not provide. This makes it more effective and more potent at lower absolute milligram doses.

Starting at the wrong dose is the most common mistake UAE buyers make. Unlike Ozempic (where the starting dose of 0.25mg is almost universally tolerated), retatrutide at even 4–6mg can cause significant nausea in the first weeks without a proper ramp-up period. The Phase 2 TRIUMPH protocol exists precisely to minimise this — follow it closely.

Phase 2 TRIUMPH Trial Dosing: The Evidence Base

The retatrutide dosing data referenced by researchers worldwide comes from the Phase 2 TRIUMPH trial published in the New England Journal of Medicine in 2023. Six dose arms were tested over 48 weeks:

Trial Arm Starting Dose Escalation Maximum Dose 48-Week Weight Loss
Arm 1 1mg/week None 1mg/week ~8.7%
Arm 2 2mg/week (4 wks) → 4mg/week 4mg/week ~17.3%
Arm 3 4mg/week None 4mg/week ~17.3%
Arm 4 2mg → 4mg → 8mg/week 8mg/week ~22.8%
Arm 5 4mg (4 wks) → 8mg/week 8mg/week ~22.8%
Arm 6 2mg → 4mg → 8mg → 12mg/week 12mg/week ~24.2%

The clear takeaway: higher doses produce greater results, with 12mg/week being the most effective studied. The most gradual escalation (Arm 6: 2mg → 4mg → 8mg → 12mg) also had the best tolerability profile.

Beginner Protocol (Weeks 1–16)

For UAE researchers new to retatrutide or those switching from Ozempic, this conservative escalation provides the best tolerability while reaching an effective maintenance dose:

Beginner Escalation Schedule

Weeks 1–42mg once weekly — this is your tolerance-building phase. Nausea is most common in this period. Inject after a meal and keep portions small.
Weeks 5–84mg once weekly — you should begin noticing appetite suppression and early weight changes.
Weeks 9–126mg once weekly — the active fat-loss phase for most people. Energy expenditure from glucagon activation increases here.
Weeks 13–168mg once weekly — approach this dose only if 6mg is well tolerated. This is an effective maintenance dose for many users.

Stay at any dose for longer than 4 weeks if you are still experiencing significant nausea or GI discomfort. There is no benefit to rushing the escalation — the compound works better when your body has adapted.

Advanced Protocol (Weeks 16+)

For researchers aiming for maximum efficacy or those who have previously tolerated 8mg well:

Advanced Escalation (after Week 16)

Weeks 17–2010mg once weekly — reserve for those who have fully adapted to 8mg with no persistent GI issues.
Week 21+12mg once weekly — the maximum Phase 2 dose. Achieved 24.2% average body weight reduction over 48 weeks. Not appropriate for all individuals.

Dosing Comparison: Retatrutide vs Mounjaro vs Ozempic

Parameter Retatrutide Mounjaro (Tirzepatide) Ozempic (Semaglutide)
Starting dose 1–2mg/week 2.5mg/week 0.25mg/week
Escalation interval Every 4 weeks Every 4 weeks Every 4 weeks
Maximum dose 12mg/week 15mg/week 2mg/week
Injection frequency Once weekly Once weekly Once weekly
Receptors activated GLP-1 + GIP + Glucagon GLP-1 + GIP GLP-1 only
Average weight loss (trials) 24.2% (48 wks, 12mg) 22.5% (72 wks, 15mg) ~15% (68 wks)

How to Reconstitute Retatrutide (Step-by-Step)

Retatrutide arrives as a white lyophilised (freeze-dried) powder in a sealed glass vial. It must be mixed with bacteriostatic water before use. Bacteriostatic water is available at coresup.shop.

Reconstitution Guide

  1. Gather supplies: retatrutide vial, bacteriostatic water (10ml), 1ml syringe, alcohol swabs
  2. Swab the vial tops of both the retatrutide vial and bacteriostatic water vial with an alcohol swab and allow to dry
  3. Draw bacteriostatic water — for a 5mg vial, draw 1ml; for a 10mg vial, draw 2ml. This gives a concentration of 5mg/ml
  4. Inject water slowly into the retatrutide vial, directing the stream against the inside glass wall — not directly onto the powder
  5. Gently swirl the vial until the powder fully dissolves — do not shake vigorously as this can degrade the peptide
  6. The solution should be clear with no particles. Discard if cloudy or coloured
  7. Label the vial with the date of reconstitution — use within 28 days

Dosing from Reconstituted Vial (5mg vial + 1ml water = 5mg/ml)

Desired Dose Volume to Draw
2mg 0.4ml (40 units on insulin syringe)
4mg 0.8ml (80 units)
6mg 1.2ml — split across two injections or use 10mg vial
8mg Use 10mg vial (2ml water = 5mg/ml) → draw 1.6ml
10mg Use 10mg vial → draw 2.0ml (full syringe × 2)
12mg Use 10mg vial → draw 2.4ml — split across two injections

Injection Technique

Retatrutide is administered as a subcutaneous (under the skin) injection — not intramuscular. The standard sites are the same as Mounjaro and Ozempic:

  • Abdomen — 5cm away from navel (most common)
  • Outer thigh
  • Upper outer arm

Rotate injection sites each week to prevent localised tissue irritation. Use a fresh 29–31 gauge needle for each injection. Pinch the skin, insert the needle at a 45–90 degree angle, inject slowly, then remove and apply gentle pressure.

Storage in Dubai and the UAE — Important

Dubai's climate requires extra attention to peptide storage. Both lyophilised and reconstituted retatrutide degrade faster in heat.

  • Lyophilised (dry) powder: Store in the fridge at 2–8°C. Do not freeze.
  • Reconstituted solution: Refrigerate at 2–8°C. Use within 28 days. Do not freeze.
  • Transport in UAE: Use an insulated cool bag with ice packs if carrying your vial anywhere. In Dubai's summer heat (35–50°C), unrefrigerated peptides can degrade within hours.
  • Power cuts: If your fridge loses power, check the vial temperature. Discard reconstituted vials that have been above 25°C for more than 48 hours.

Retatrutide During Ramadan: UAE-Specific Guidance

Many UAE residents using retatrutide during Ramadan ask whether weekly injections can continue during the fasting period. The answer is generally yes, with adjustments:

  • Injection timing: Administer your weekly dose at Iftar (sunset, breaking of fast) when food intake begins — this minimises nausea by aligning the injection with eating
  • Start Iftar slowly: Retatrutide's appetite suppression means smaller meals are needed — avoid large Iftar meals which increase nausea risk
  • Hydration: Stay well hydrated during non-fasting hours (Iftar to Suhoor); GLP-1 agonists can cause dehydration through vomiting or reduced fluid intake
  • Blood sugar monitoring: If using retatrutide for metabolic research related to type 2 diabetes, monitor glucose more closely during Ramadan as fasting changes insulin dynamics

Consult a physician for individual guidance if you have any medical conditions.

Order Retatrutide and Supplies — Delivered Across UAE

Retatrutide vials, bacteriostatic water, and insulin syringes available at Core Sup. Same-day delivery to Dubai and Abu Dhabi.

Shop at Core Sup

Managing Side Effects During Dose Escalation

Nausea is the most common side effect during the titration phase, particularly in the first 2–4 weeks after each dose increase. UAE researchers report these strategies help:

  • Inject after a small meal, not on an empty stomach
  • Avoid spicy and fatty foods on injection day — particularly relevant for UAE cuisine
  • Eat smaller portions: appetite suppression is intense at first
  • Stay hydrated — drink 2–3 litres of water daily, more in Dubai's heat
  • If nausea is severe, hold the current dose for 2 additional weeks before escalating further

Full side effect details are in our Retatrutide Side Effects guide.

What to Do If You Miss a Dose

If you miss your weekly injection:

  • Less than 4 days late: Take the dose as soon as you remember
  • 4 or more days late: Skip the missed dose and resume on your normal schedule next week — do not double-dose
  • After a break of 2 or more weeks, consider stepping back one dose level for 4 weeks before resuming your previous dose

Related Guides

Research Compound Notice: Retatrutide is sold by Core Sup as a research compound for scientific research purposes only. It is not approved by the FDA, MOHAP, or equivalent regulatory agencies for human therapeutic use. This dosage information is based on Phase 2 clinical trial protocols published in the NEJM (2023) and does not constitute medical advice. Always consult a licensed medical professional before use.

Back to blog